Closed · RFA-DC-11-002 · CFDA 93.173 · Discretionary

Identification of Immune-Mediated Causes of Sensorineural Hearing Loss (R21/R33)

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

Varies
Award range
Closed
Status
June 8, 2011
Close date
-
Expected awards

The verdict

Identification of Immune-Mediated Causes of Sensorineural Hearing Loss (R21/R33) is a closed discretionary listing from National Institutes of Health that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.

Varies
award range
Closed
application status
93.173
CFDA program
12,419
other opportunities from National Institutes of Health

Archived opportunity record

Identification of Immune-Mediated Causes of S… is closed (last close June 8, 2011). The parent program page for CFDA 93.173 is the reliable place to catch re-announcements. National Institutes of Health still indexes 12,419 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed June 8, 2011

Posted Aug 18 Closes Jun 8

Instrument

Grant

Description

Purpose. The purpose of this FOA is to encourage submission of milestone-driven interdisciplinary Exploratory/Developmental Phased Innovation (R21/R33) research proposals designed to further our understanding of the mechanism, etiology, and pathophysiology of immune mediated sensorineural hearing loss (IMSNHL). Applications considered responsive include studies of 1) ear organ-specific autoimmune sensorineural hearing loss - i.e. autoimmune inner ear disease (AIED), 2) sudden sensorineural hearing loss attributable to AIED, as well as 3) sensorineural hearing loss associated with systemic autoimmune disease. Proposals primarily involving human subjects/tissues will be given highest priority. The human health goal of this FOA is the ultimate translation of the research findings into clinical biomarkers, new diagnostic tests with high sensitivity, specificity and positive predictive value, and the development of therapies that preserve natural hearing. Mechanism of Support. This FOA will utilize the R21/R33 Exploratory/Developmental Phased Innovation grant mechanism. Funds Available and Anticipated Number of Awards. NIDCD has set aside $700K in FY2011 and $1.3M in FY2012 in anticipation of 2-3 awards per application cycle.

Market-open applicant set · includes for-profit door

The eligibility set for Identification of Immune-Mediated Causes of S… includes a for-profit door among 10 printed types (State governments; Public / state-controlled institutions of higher education; Federally recognized tribal governments; Native American tribal organizations (other than Federally recognized tribal governments); +6 more). Competitive traffic can include commercial applicants alongside other listed classes. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). Only 91 other National Institutes of Health listings share this exact eligibility-code string (1% of 12,420).

Code 00
State governments
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 22
For-profit organizations other than small businesses
Code 23
Small businesses
Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

What to do next

Identification of Immune-Mediated Causes of S… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.173 may publish future NOFOs under the same assistance listing. Open program
  • Research on Healthcare Costs indexes 118 Grants.gov listings in this extract. Program profile
  • National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants